BioSight
Companies
KAZIA THERAPEUTICS LTD logo

KZIA

NASDAQSYDNEY NSW
KAZIA THERAPEUTICS LTD

Kazia Therapeutics develops drug candidates across multiple therapeutic areas, though the specific programs and modalities are not detailed in this excerpt. Kazia relies on contract research organizations and contract manufacturers to advance its clinical trials and produce development materials. The company is in clinical-stage development, with operations dependent on securing funding to complete further development and potential commercialization of its product candidates.

Price history not yet available for KZIA.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar